SNOT-22 in a control population

Sally Erskine, Claire Hopkins, Allan Clark, Shahram Anari, Nirmal Kumar, Alasdair Robertson, Vishnu Sunkaraneni, J. A. Wilson, Sean Carrie, Naveed Kara, Jaydip Ray, R. Smith, Carl Philpott, CRES group

Research output: Contribution to journalArticlepeer-review

26 Citations (Scopus)
24 Downloads (Pure)


AIM: To assess SNOT-22 and its subscales in a non-rhinosinusitis UK-wide population. 

METHODOLOGY/PRINCIPLE: This analysis uses data from the 'Chronic Rhinosinusitis Epidemiology Study' (CRES) which recruited from 30 centres across the UK, and the Socioeconomic Cost of ChrOnic Rhinosinusitis study' (SocCoR); 250 volunteers without CRS were recruited as part of these studies. Study-specific questionnaires including demographics, socioeconomic factors and past medical history as well as SNOT-22 and SF-36 were distributed. The control (non-CRS) population had no self-reported nasal problems in the past, no chronic conditions undergoing active treatment and no hospital admissions in the preceding 12 months. 

RESULTS: The mean SNOT-22 total score overall was 12.0. The mean was 10.2 for males with a median of 6.5, and a mean of 13.2 for females with a median of 9. Females scored significantly more highly than males on the sleep/fatigue and facial domains. 

CONCLUSIONS: Our data demonstrate differences in SNOT-22 amongst males and females. These data can be used in future studies for comparison with different disease populations with rhinosinusitis. This article is protected by copyright. All rights reserved. 

Original languageEnglish
Pages (from-to)81–85
Number of pages5
JournalClinical Otolaryngology
Issue number1
Early online date5 May 2016
Publication statusPublished - Feb 2017


  • Sinonasal Outcome Test
  • Control population

Cite this